Table (4).
Study | IL-1β pg/μL | TNFα pg/μL | ||||
---|---|---|---|---|---|---|
groups | Baseline | After Therapy | P | Baseline | After therapy | P |
GI | 131.35±54.23 | 115.45±67.12 | >0.05 | 26.65±23.67 | 21.54±68.13 | >0.05 |
GII | 126.45±76.16 | 73.17±61.25 | <0.001 | 17.78±11.04 | 6.71±2.34 | <0.001 |
P | >0.05 | <0.001 | _ | <0.005 | <0.001 | __ |
Healthy group (Group III) | 80.01±12.76 | __ | _ | 3.20±1.39 | __ | __ |
P | <0.001 | __ | _ | <0.001 | __ | __ |